Healthcare Sales & Marketing Network News: EURIDIS

Searching News Database: EURIDIS

HSMN NewsFeed - 30 Nov 2009
sanofi-aventis: Multaq(R) Approved in the European Union for Patients With Atrial Fibrillation
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 2 Jul 2009
FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 15 May 2008
Landmark ATHENA Study Findings With Multaq(R)(dronedarone) Show 24% Reduction in Cardiovascular Hospitalisation or Death in Patients With Atrial Fibrillation
Biopharmaceuticals Cardiology

HSMN NewsFeed - 5 Sep 2007
The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
Biopharmaceuticals Cardiology

Return to NewsFeed

Additional items found! 3

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 3 additional stories matching:
EURIDIS
(Password required)

FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!